175 related articles for article (PubMed ID: 7262643)
1. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
Breuer JH; Harsányi V; Solti V; Hollán SR
Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
[TBL] [Abstract][Full Text] [Related]
2. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
[TBL] [Abstract][Full Text] [Related]
3. Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis.
Clezardin P; McGregor JL; Dechavanne M; Clemetson KJ
Br J Haematol; 1985 Jun; 60(2):331-44. PubMed ID: 4005182
[TBL] [Abstract][Full Text] [Related]
4. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
Boughton BJ; Allington MJ; King A
Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
[TBL] [Abstract][Full Text] [Related]
5. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
6. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
7. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
8. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory assessment of a patient with thrombocytosis.
Appleby N; Angelov D
Br J Hosp Med (Lond); 2017 Oct; 78(10):558-564. PubMed ID: 29019736
[TBL] [Abstract][Full Text] [Related]
10. Platelet function in patients with high platelet counts.
Ginsburg AD
Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
[TBL] [Abstract][Full Text] [Related]
11. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
[No Abstract] [Full Text] [Related]
12. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
[TBL] [Abstract][Full Text] [Related]
13. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
14. Some aspects of platelet glucose metabolism in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Armani U; Piana A
Thromb Res; 1984 May; 34(3):233-9. PubMed ID: 6729778
[TBL] [Abstract][Full Text] [Related]
15. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
Culebras Poza JM; Launay JM; Briere J; Dreux C
Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
[TBL] [Abstract][Full Text] [Related]
16. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.
Bautista AP; Buckler PW; Towler HM; Dawson AA; Bennett B
Br J Haematol; 1984 Dec; 58(4):679-87. PubMed ID: 6240280
[TBL] [Abstract][Full Text] [Related]
17. Platelet miR-28 expression level and thrombocytosis in MPN patients.
Stolyar MA; Gorbenko AS; Olkhovskiy IA
Int J Lab Hematol; 2019 Apr; 41(2):e43-e45. PubMed ID: 30480878
[No Abstract] [Full Text] [Related]
18. Effects of in vitro platelet activation on platelet derived nitric oxide production in healthy humans and in chronic myeloproliferative diseases with elevated platelet counts.
Rejto L; Huszka M; Káplár M; Udvardy M
Platelets; 2003 Aug; 14(5):283-6. PubMed ID: 14524361
[TBL] [Abstract][Full Text] [Related]
19. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
20. Altered platelet phospholipid-dependent thrombin generation in thrombocytopenia and thrombocytosis.
Lee LH; Baglin T
Br J Haematol; 1995 Jan; 89(1):131-6. PubMed ID: 7833251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
